Press Release Jul 29 2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg

View Attachment